Day: April 28, 2021

Agenus to Present at the 2021 ASCO Annual Meeting

Agenus to Present at the 2021 ASCO Annual Meeting

LEXINGTON, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that it will give two presentations at the 2021 American Society for Clinical Oncology (ASCO) Annual Meeting poster sessions. The ASCO meeting will be held from June 4 – 8, 2021. Presentation Details: Abstract title: Differentiated activity profile for the PD-1 inhibitor balstilimabAbstract number: 5529Poster Session: Gynecologic CancerPresenting author: Cailin Joyce, PhD Abstract title: Initial findings of the first-in-human Phase I study of AGEN2373, a conditionally active CD137 agonist antibody, in patients (pts) with advanced solid tumors Abstract number:...

Continue reading

CF Energy Announces Financial Results For The Year ended December 31, 2020

CF Energy Announces Financial Results For The Year ended December 31, 2020

TORONTO, April 28, 2021 (GLOBE NEWSWIRE) — CF Energy Corp., (TSX-V: CFY) (“CF Energy” or the “Company”, together with its subsidiaries, the “Group”), an energy provider in the People’s Republic of China (the ”PRC” or “China”), announces that the Company has filed its audited consolidated financial results for the year ended December 31, 2020. Results for the year ended December 31, 2020 In millions 2020   2019   Change   % 2020   2019   Change   % (except for % figures) RMB   RMB   RMB     CAD   CAD   CAD     Revenue 368.2   438.0   (69.8 ) -16 % 71.6   84.2   (12.6 ) -15 % Gross Profit 140.1   174.7   (34.6 ) -20 % 27.2   33.6   (6.4 ) -19 % Gross Profit Margin 38.1 % 39.9 % -1.8 %   38.1 % 39.9 % -1.8 %   Net Profit 45.6   47.2   (1.6 ) -3 % 8.9   9.1   (0.2 ) -2 % Adjusted net Profit 36.2   45.8   (9.6 ) -21 % 7.2   8.9   (1.7 ) -19 % EBITDA 91.5   96.4   (4.9 ) -5 % 17.7   18.4   (0.7 ) -4 % Adjusted...

Continue reading

Apollo Global Management to Announce First Quarter 2021 Financial Results

Apollo Global Management to Announce First Quarter 2021 Financial Results

NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) announced today that it will host a conference call to review Apollo’s financial results on Tuesday, May 04, 2021 at 8:30 a.m. EST as previously stated. The Company has amended the timing of releasing its first quarter 2021 results to Tuesday, May 04, 2021 at 7 a.m. EST. The conference call may be accessed by dialing (833) 614-1406 (U.S. domestic) or +1 (914) 987-7127 (international), and providing conference call ID 5576528 when prompted by the operator. The number should be dialed at least ten minutes prior to the start of the call. A simultaneous webcast of the conference call will be available to the public on a listen-only basis and can be accessed through the Stockholders section of...

Continue reading

Oil States Announces First Quarter 2021 Results of Operations

Oil States Announces First Quarter 2021 Results of Operations

HOUSTON, April 28, 2021 (GLOBE NEWSWIRE) — Oil States International, Inc. (NYSE: OIS) reported a net loss of $15.8 million, or $0.26 per share, for the first quarter of 2021, which included non-cash fixed asset impairment charges of $0.7 million ($0.5 million after-tax, or $0.01 per share), severance and restructuring charges of $3.4 million ($2.7 million after-tax, or $0.04 per share) and non-cash gains on extinguishment of convertible senior notes of $3.6 million ($2.9 million after-tax, or $0.05 per share). During the first quarter of 2021, the Company generated revenues of $125.6 million and Adjusted Consolidated EBITDA (Note A) of $6.1 million (excluding $3.4 million of severance and restructuring charges). These results compare to revenues of $137.4 million and Adjusted Consolidated EBITDA of $2.2 million reported in the...

Continue reading

Triterras Expands Board of Directors

Triterras Expands Board of Directors

SINGAPORE, April 28, 2021 (GLOBE NEWSWIRE) — Triterras Inc. (Nasdaq: TRIT, TRITW) (“Triterras” or the “Company”), a leading fintech company for trade and trade finance, has appointed Yong-Moon Kim, Jayapal Ramasamy and Lilian Koh to the board of directors, effective immediately, replacing Directors Matthew Richards and Vanessa Slowey who resigned. With these changes, the Triterras Board of Directors expands to eight total members, five of whom are independent.   All three new directors will be independent. “On behalf of the entire organization, I would like to welcome Mr. Kim, Mr. Jayapal, and Ms. Koh to our Board of Directors,” said Srinivas Koneru, Chairman and CEO of Triterras. “All three individuals bring unique and valuable experiences to our company and we look forward to benefitting from their collective insights and extraordinary...

Continue reading

AirBoss Announces Amended Credit Facilities

AirBoss Announces Amended Credit Facilities

NEWMARKET, Ontario, April 28, 2021 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”) today announced that it has amended its senior secured revolving credit facilities to increase its credit availability from US$60 million to US$150 million on substantially the same terms, conditions and maturity as its current credit facilities. The increased facilities are intended to cover upfront costs necessary to execute on the Company’s purchase order expected to be worth up to US$288 million to supply the U.S. Department for Health and Human Services (HHS) – Office of the Assistant Secretary for Preparedness and Response (ASPR) with nitrile patient examination gloves. There are no other substantive changes to the Company’s credit facilities. The syndicate of lenders will continue...

Continue reading

Ashland reports preliminary financial results1 for second quarter of fiscal year 2021

Ashland reports preliminary financial results1 for second quarter of fiscal year 2021

Sales of $598 million, down two percent from the prior-year quarter Net income of $41 million, or $0.66 per diluted share Income from continuing operations of $43 million, or $0.69 per diluted share Adjusted income from continuing operations excluding intangibles amortization expense of $64 million, or $1.05 per diluted share Adjusted EBITDA of $134 million Cash flows provided by operating activities of $64 million; free cash flows of $40 million WILMINGTON, Del., April 28, 2021 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced preliminary1 financial results for the second quarter of fiscal year 2021, which ended March 31, 2021. The global specialty materials company serves customers in a wide range of consumer and industrial markets. Ashland’s financial results during the quarter reflected execution...

Continue reading

Amerant Reports First Quarter 2021 Net Income of $14.5 Million, Diluted Earnings Per Share of $0.38

Amerant Reports First Quarter 2021 Net Income of $14.5 Million, Diluted Earnings Per Share of $0.38

Originated $81.5 million in Paycheck Protection Program (“PPP”) loans; Reached $2 billion in Assets Under Management (“AUM”) CORAL GABLES, Fla., April 28, 2021 (GLOBE NEWSWIRE) — Amerant Bancorp Inc. (NASDAQ: AMTB and AMTBB) (the “Company” or “Amerant”) today reported net income of $14.5 million in the first quarter of 2021, or $0.38 per diluted share, compared to $8.5 million, or $0.20 per diluted share, in the fourth quarter of 2020 and $3.4 million, or $0.08 per diluted share, in the first quarter of 2020. Pre-provision net revenue (“PPNR”) (non-GAAP) was $18.1 million in the first quarter of 2021, an increase from $8.5 million in the fourth quarter of 2020, and a decrease from $26.3 million in the first quarter of 2020. Annualized return on assets (“ROA”) and return on equity (“ROE”) were 0.76% and 7.47%, respectively, in the...

Continue reading

Reata Pharmaceuticals, Inc. To Report First Quarter 2021 Financials and To Provide an Update on Development Programs on May 6, 2021

Reata Pharmaceuticals, Inc. To Report First Quarter 2021 Financials and To Provide an Update on Development Programs on May 6, 2021

PLANO, Texas, April 28, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs pre-market on May 6, 2021. Reata’s management will host a conference call on May 6, 2021 at 8:30 am ET. The conference call will be accessible by dialing (866) 270-1533 (toll-free domestic) or (412) 317-0797 (international) using the access code: 10153548. The webcast link is https://event.on24.com/wcc/r/3080993/647A7195D390CEF8F5FA6FFA73CD7C87. First quarter 2021 financial results to be discussed during the call will be included in an earnings press release that will be available on the Company’s website shortly before the call at http://reatapharma.com/investors/...

Continue reading

Methanex Reports Strong First Quarter 2021 Results

Methanex Reports Strong First Quarter 2021 Results

Except where otherwise noted, all currency amounts are stated in United States dollars. Net income attributable to Methanex shareholders rose to $105 million, supported by higher methanol prices Adjusted EBITDA rose to $242 million, the highest quarterly result since the third quarter of 2018. Completed a planned turnaround at the Geismar 2 plant and we expect to complete the Geismar 2 debottlenecking project by mid-2021. Strong liquidity position and financial flexibility with over $850 million in cash, a $300 million undrawn credit facility and no debt maturities until the end of 2024. VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) — For the first quarter of 2021, Methanex (TSX:MX) (NASDAQ:MEOH) reported net income attributable to Methanex shareholders of $105 million ($1.19 net income per common share on a diluted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.